For those interested, I've updated the potential CPACS candidate list to include the drugs named in our 'WO2023087065 - METHOD OF CARDIOPROTECTION' patent application* - https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2023087065&_cid=P20-LVZPIU-67488-1
*Note that there is a broad brush inclusion of Zan in combination with any cardiotoxic therapeutic agent:
"A pharmaceutical composition comprising a cardioprotective agent comprising bisantrene or a derivative thereof, or a pharmaceutically acceptable salt of bisantrene or derivative thereof, and a cardiotoxic therapeutic agent, said composition having reduced cardiotoxicity compared to a composition comprising said cardiotoxic therapeutic agent but not comprising said cardioprotective agent."
Why is this significant?
The Triangle market research report notes a global peak sales potential of ~US$5-8B in breast, gynaecologic, sarcoma and liquid tumors, when Zan is used in combination with an anthracycline (that's only 6 of the 25 drugs listed above). The CPACS TAM is greater than just the Anthracycline market.
Further, 6 months after the publication of the Triangle report, RAC announced the Oncolines work.
This work expands the ~US$5-8B Anthracycline synergy market opportunity noted in the Triangle report by an additional 10 indications.
- Forums
- ASX - By Stock
- RAC
- Cardioprotection thread
Cardioprotection thread, page-512
-
-
- There are more pages in this discussion • 101 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.83 |
Change
0.020(1.11%) |
Mkt cap ! $309.0M |
Open | High | Low | Value | Volume |
$1.81 | $1.83 | $1.80 | $39.44K | 21.76K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 70 | $1.82 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.84 | 2980 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 70 | 1.815 |
1 | 563 | 1.810 |
2 | 2850 | 1.805 |
3 | 22257 | 1.800 |
3 | 6204 | 1.795 |
Price($) | Vol. | No. |
---|---|---|
1.835 | 2980 | 1 |
1.840 | 432 | 1 |
1.845 | 2746 | 1 |
1.850 | 2422 | 2 |
1.855 | 427 | 1 |
Last trade - 12.01pm 28/06/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online